XML 79 R69.htm IDEA: XBRL DOCUMENT v3.23.3

Intangible Assets - Product Distribution Rights and Customer List (Details) - Innovus Pharmaceuticals, Inc $ in Millions	1 Months Ended	12 Months Ended
	Feb. 29, 2020 item product	Jun. 30, 2023 USD ($)
Business Acquisition [Line Items]
Number of products acquired | product	35
Number of registered trademarks and or patent rights and customer lists acquired | item	300
Consumer Health Segment
Business Acquisition [Line Items]
Impairment of intangible assets, finite-lived | $		$ 3.0

X

- Definition

Number of Products Acquired

+ References

No definition available.

+ Details

Name:	aytu_NumberOfProductsAcquired
Namespace Prefix:	aytu_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of Registered Trademarks and or Patent Rights and Customer Lists Acquired

+ References

No definition available.

+ Details

Name:	aytu_NumberOfRegisteredTrademarksAndOrPatentRightsAndCustomerListsAcquired
Namespace Prefix:	aytu_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479907/805-20-50-5

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-28

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482665/350-30-50-3

+ Details

Name:	us-gaap_ImpairmentOfIntangibleAssetsFinitelived
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=aytu_InnovusPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=aytu_ConsumerHealthMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: